Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 958097, 15 pages
http://dx.doi.org/10.1155/2015/958097
Research Article

Is Vitamin D Deficiency Related to Accumulation of Advanced Glycation End Products, Markers of Inflammation, and Oxidative Stress in Diabetic Subjects?

1Comenius University Medical Faculty, 811 07 Bratislava, Slovakia
2University of Würzburg, 97080 Würzburg, Germany
3KfH Nierenzentrum Würzburg, 97080 Würzburg, Germany
4Beiersdorf AG, Hamburg, Germany

Received 1 November 2014; Revised 12 January 2015; Accepted 27 January 2015

Academic Editor: Jun Ren

Copyright © 2015 K. Šebeková et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Brownlee, “Lilly lecture 1993. Glycation and diabetic complications,” Diabetes, vol. 43, no. 6, pp. 836–841, 1994. View at Publisher · View at Google Scholar
  2. T. Miyata, Y. Wada, Z. Cai et al., “Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure,” Kidney International, vol. 51, no. 4, pp. 1170–1181, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Gugliucci and M. Bendayan, “Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells,” Diabetologia, vol. 39, no. 2, pp. 149–160, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Uribarri, S. Woodruff, S. Goodman et al., “Advanced glycation end products in foods and a practical guide to their reduction in the diet,” Journal of the American Dietetic Association, vol. 110, no. 6, pp. 911–916, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Šebeková, K. S. Klenovics, P. Boor et al., “Behaviour and hormonal status in healthy rats on a diet rich in Maillard reaction products with or without solvent extractable aroma compounds,” Physiology and Behavior, vol. 105, no. 3, pp. 693–701, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Cerami, H. Founds, I. Nicholl et al., “Tobacco smoke is a source of toxic reactive glycation products,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 25, pp. 13915–13920, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Zieman and D. Kass, “Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease,” Congestive Heart Failure, vol. 10, no. 3, pp. 144–151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Haus, J. A. Carrithers, S. W. Trappe, and T. A. Trappe, “Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle,” Journal of Applied Physiology, vol. 103, no. 6, pp. 2068–2076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. P. J. Thornalley, “Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs,” Cellular and Molecular Biology (Noisy-le-Grand, France), vol. 44, no. 7, pp. 1013–1023, 1998. View at Google Scholar · View at Scopus
  10. G. Rashid, S. Benchetrit, D. Fishman, and J. Bernheim, “Effect of advanced glycation end-products on gene expression and synthesis of TNF-α and endothelial nitric oxide synthase by endothelial cells,” Kidney International, vol. 66, no. 3, pp. 1099–1106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Ohgami, A. Miyazaki, M. Sakai, A. Kuniyasu, H. Nakayama, and S. Horiuchi, “Advanced glycation end products (AGE) inhibit scavenger receptor class B type I-mediated reverse cholesterol transport: a new crossroad of AGE to cholesterol metabolism,” Journal of Atherosclerosis and Thrombosis, vol. 10, no. 1, pp. 1–6, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Schupp, R. Schinzel, A. Heidland, and H. Stopper, “Genotoxicity of advanced glycation end products: involvement of oxidative stress and of angiotensin II type 1 receptors,” Annals of the New York Academy of Sciences, vol. 1043, pp. 685–695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Šebeková, Z. Wagner, N. Schupp, and P. Boor, “Genomic damage and malignancy in end-stage renal failure: do advanced glycation end products contribute?” Kidney and Blood Pressure Research, vol. 30, no. 1, pp. 56–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Bucala and A. Cerami, “Advanced glycosylation: chemistry, biology, and implications for diabetes and aging,” Advances in Pharmacology, vol. 23, pp. 1–34, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Moran, G. Münch, J. M. Forbes et al., “Type 2 diabetes, skin autofluorescence, and brain atrophy,” Diabetes, vol. 64, no. 1, pp. 279–283, 2014. View at Publisher · View at Google Scholar
  16. M. T. Coughlan, F. Y. T. Yap, D. C. K. Tong et al., “Advanced glycation end products are direct modulators of β-cell function,” Diabetes, vol. 60, no. 10, pp. 2523–2532, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. J. Hunter, A. C. Boyd, F. P. M. O'Harte et al., “Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans,” Diabetes, vol. 52, no. 2, pp. 492–498, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. J. W. L. Hartog, A. A. Voors, S. J. L. Bakker, A. J. Smit, and D. J. van Veldhuisen, “Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications,” European Journal of Heart Failure, vol. 9, no. 12, pp. 1146–1155, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Lapolla, F. Piarulli, G. Sartore et al., “Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease,” Diabetes Care, vol. 30, no. 3, pp. 670–676, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. L. Melamed, E. D. Michos, W. Post, and B. Astor, “25-hydroxyvitamin D levels and the risk of mortality in the general population,” Archives of Internal Medicine, vol. 168, no. 15, pp. 1629–1637, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. B. K. Kilhovd, A. Juutilainen, S. Lehto et al., “Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study,” Diabetologia, vol. 50, no. 7, pp. 1409–1417, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Wagner, M. Molnár, G. A. Molnár et al., “Serum carboxymethyllysine predicts mortality in hemodialysis patients,” American Journal of Kidney Diseases, vol. 47, no. 2, pp. 294–300, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Raucci, S. Cugusi, A. Antonelli et al., “A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10),” The FASEB Journal, vol. 22, no. 10, pp. 3716–3727, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Meerwaldt, R. Graaf, P. H. N. Oomen et al., “Simple non-invasive assessment of advanced glycation endproduct accumulation,” Diabetologia, vol. 47, no. 7, pp. 1324–1330, 2004. View at Google Scholar · View at Scopus
  25. R. Meerwaldt, C. J. Zeebregts, G. Navis, J.-L. Hillebrands, J. D. Lefrandt, and A. J. Smit, “Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis,” The American Journal of Kidney Diseases, vol. 53, no. 1, pp. 138–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. D. J. Mulder, T. van de Water, H. L. Lutgers et al., “Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations,” Diabetes Technology and Therapeutics, vol. 8, no. 5, pp. 523–535, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. N. J. Mcintyre, R. J. Fluck, C. W. Mcintyre, and M. W. Taal, “Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 10, pp. 2356–2363, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. F. Holick, “Vitamin D deficiency,” TheNew England Journal of Medicine, vol. 357, no. 3, pp. 266–281, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. T. J. Wang, M. J. Pencina, S. L. Booth et al., “Vitamin D deficiency and risk of cardiovascular disease,” Circulation, vol. 117, no. 4, pp. 503–511, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. C. Li, J. Kong, M. Wei, Z.-F. Chen, S. Q. Liu, and L.-P. Cao, “1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system,” The Journal of Clinical Investigation, vol. 110, no. 2, pp. 229–238, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Scragg, M. Sowers, and C. Bell, “Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey,” The American Journal of Hypertension, vol. 20, no. 7, pp. 713–719, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Pilz, A. Tomaschitz, E. Ritz, and T. R. Pieber, “Vitamin D status and arterial hypertension: a systematic review,” Nature Reviews Cardiology, vol. 6, no. 10, pp. 621–630, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Al Mheid, R. Patel, J. Murrow et al., “Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans,” Journal of the American College of Cardiology, vol. 58, no. 2, pp. 186–192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. K. E. Watson, M. L. Abrolat, L. L. Malone et al., “Active serum vitamin D levels are inversely correlated with coronary calcification,” Circulation, vol. 96, no. 6, pp. 1755–1760, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. I. H. de Boer, B. Kestenbaum, A. B. Shoben, E. D. Michos, M. J. Sarnak, and D. S. Siscovick, “25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification,” Journal of the American Society of Nephrology, vol. 20, no. 8, pp. 1805–1812, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Pilz, H. Dobnig, J. E. Fischer et al., “Low vitamin D levels predict stroke in patients referred to coronary angiography,” Stroke, vol. 39, no. 9, pp. 2611–2613, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. A. F. Gombart, N. Borregaard, and H. P. Koeffler, “Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3,” The FASEB Journal, vol. 19, no. 9, pp. 1067–1077, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Balion, L. E. Griffith, L. Strifler et al., “Vitamin D, cognition, and dementia: a systematic review and meta-analysis,” Neurology, vol. 79, no. 13, pp. 1397–1405, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Mattila, P. Knekt, S. Männistö et al., “Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes,” Diabetes Care, vol. 30, no. 10, pp. 2569–2570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. A. W. Norman, B. J. Frankel, A. M. Heldt, and G. M. Grodsky, “Vitamin D deficiency inhibits pancreatic secretion of insulin,” Science, vol. 209, no. 4458, pp. 823–825, 1980. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Guo, Z. Xiao, X. Xue et al., “25-hydroxyvitamin D is closely related with the function of the pancreatic islet β cells,” Pakistan Journal of Medical Sciences, vol. 29, no. 3, pp. 809–813, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. C. V. Harinarayan, S. Arvind, S. Joshi, K. Thennarasu, V. Vedavyas, and A. Baindur, “Improvement in pancreatic β-cell function with vitamin D and calcium supplementation in vitamin D deficient non-diabetic subjects,” Endocrine Practice, vol. 20, no. 2, pp. 129–138, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. A. G. Pittas, J. Lau, F. B. Hu, and B. Dawson-Hughes, “The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 6, pp. 2017–2029, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. D. P. Choi, S. M. Oh, J. M. Lee et al., “Serum 25-hydroxyvitamin D and insulin resistance in apparently healthy adolescents,” PLoS ONE, vol. 9, Article ID e103108, 2014. View at Google Scholar
  45. A. Badawi, S. Sayegh, E. Sadoun, M. Al-Thani, P. Arora, and P. S. Haddad, “Relationship between insulin resistance and plasma vitamin D in adults,” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 7, pp. 297–303, 2014. View at Publisher · View at Google Scholar
  46. C. Joergensen, P. Hovind, A. Schmedes, H.-H. Parving, and P. Rossing, “Vitamin D levels, microvascular complications, and mortality in type 1 diabetes,” Diabetes Care, vol. 34, no. 5, pp. 1081–1085, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. C. M. Girgis, R. J. Clifton-Bligh, M. W. Hamrick, M. F. Holick, and J. E. Gunton, “The roles of vitamin D in skeletal muscle: form, function, and metabolism,” Endocrine Reviews, vol. 34, no. 1, pp. 33–83, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Talmor, E. Golan, S. Benchetrit et al., “Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells,” American Journal of Physiology: Renal Physiology, vol. 294, no. 5, pp. F1059–F1064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Salum, J. Kals, P. Kampus et al., “Vitamin D reduces deposition of advanced glycation end-products in the aortic wall and systemic oxidative stress in diabetic rats,” Diabetes Research and Clinical Practice, vol. 100, no. 2, pp. 243–249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Münch, R. Keis, A. Wessels et al., “Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA1),” European Journal of Clinical Chemistry and Clinical Biochemistry, vol. 35, no. 9, pp. 669–677, 1997. View at Google Scholar · View at Scopus
  51. P. Pludowski, W. B. Grant, H. P. Bhattoa et al., “Vitamin D status in central Europe,” International Journal of Endocrinology, vol. 2014, Article ID 589587, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. G. S. Maier, P. Jakobs, K. E. Roth, A. A. Kurth, and U. Maus, “Is there an epidemic vitamin D deficiency in German orthopaedic patients?” Clinical Orthopaedics and Related Research, vol. 471, no. 9, pp. 3029–3035, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Mitri, M. D. Muraru, and A. G. Pittas, “Vitamin D and type 2 diabetes: a systematic review,” European Journal of Clinical Nutrition, vol. 65, no. 9, pp. 1005–1015, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. N. G. Forouhi, Z. Ye, A. P. Rickard et al., “Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of Prospective studies,” Diabetologia, vol. 55, no. 8, pp. 2173–2182, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Gradinaru, C. Borsa, C. Ionescu, D. Margina, G. I. Prada, and E. Jansen, “Vitamin D status and oxidative stress markers in the elderly with impaired fasting glucose and type 2 diabetes mellitus,” Aging Clinical and Experimental Research, vol. 24, no. 6, pp. 595–602, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Song, L. Wang, A. G. Pittas et al., “Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies,” Diabetes Care, vol. 36, no. 5, pp. 1422–1428, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. K. C. Chiu, A. Chu, V. L. W. Go, and M. F. Saad, “Hypovitaminosis D is associated with insulin resistance and β cell dysfunction,” American Journal of Clinical Nutrition, vol. 79, no. 5, pp. 820–825, 2004. View at Google Scholar · View at Scopus
  58. X. Palomer, J. M. González-Clemente, F. Blanco-Vaca, and D. Mauricio, “Role of vitamin D in the pathogenesis of type 2 diabetes mellitus,” Diabetes, Obesity and Metabolism, vol. 10, no. 3, pp. 185–197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. M. S. Hutchinson, Y. Figenschau, I. Njølstad, H. Schirmer, and R. Jorde, “Serum 25-hydroxyvitamin D levels are inversely associated with glycated haemoglobin (HbA1c). The Tromsø Study,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 71, no. 5, pp. 399–406, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. G. Zoppini, A. Galletti, G. Targher et al., “Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients,” PLoS ONE, vol. 8, no. 12, Article ID e82733, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. J. C. Seida, J. Mitri, I. N. Colmers et al., “Effect of vitamin d3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 10, pp. 3551–3560, 2014. View at Publisher · View at Google Scholar
  62. P. Autier, M. Boniol, C. Pizot, and P. Mullie, “Vitamin D status and ill health: a systematic review,” The Lancet Diabetes and Endocrinology, vol. 2, no. 1, pp. 76–89, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. E. B. Mawer, J. Backhouse, C. A. Holman, G. A. Lumb, and S. W. Stanbury, “The distribution and storage of vitamin D and its metabolites in human tissues,” Clinical Science, vol. 43, no. 3, pp. 413–431, 1972. View at Google Scholar · View at Scopus
  64. B. D. Piccolo, G. Dolnikowski, E. Seyoum et al., “Association between subcutaneous white adipose tissue and serum 25-hydroxyvitamin D in overweight and obese adults,” Nutrients, vol. 5, no. 9, pp. 3352–3366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. K. S. Vimaleswaran, A. Cavadino, D. J. Berry et al., “Genetic association analysis of vitamin D pathway with obesity traits,” International Journal of Obesity, vol. 37, no. 10, pp. 1399–1406, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Koetsier, H. L. Lutgers, C. de Jonge, T. P. Links, A. J. Smit, and R. Graaff, “Reference values of skin autofluorescence,” Diabetes Technology and Therapeutics, vol. 12, no. 5, pp. 399–403, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. R. Meerwaldt, T. P. Links, R. Graaff et al., “Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy,” Diabetologia, vol. 48, no. 8, pp. 1637–1644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. E. G. Gerrits, H. L. Lutgers, N. Kleefstra et al., “Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications,” Diabetes Care, vol. 31, no. 3, pp. 517–521, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Škrha, J. Šoupal, G. Loni Ekali et al., “Skin autofluorescence relates to soluble receptor for advanced glycation end-products and albuminuria in diabetes mellitus,” Journal of Diabetes Research, vol. 2013, Article ID 650694, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Kalousová, J. Škrha, and T. Zima, “Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus,” Physiological Research, vol. 51, no. 6, pp. 597–604, 2002. View at Google Scholar · View at Scopus
  71. M. J. Ala-Houhala, K. Vähävihu, T. Hasan et al., “Narrow-band ultraviolet B exposure increases serum vitamin D levels in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 27, no. 6, pp. 2435–2440, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, “Obesity induces a phenotypic switch in adipose tissue macrophage polarization,” The Journal of Clinical Investigation, vol. 117, no. 1, pp. 175–184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Mazzone, “Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data,” Circulation, vol. 122, no. 21, pp. 2201–2211, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Chandra, I. J. Neeland, J. D. Berry et al., “The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study,” Journal of the American College of Cardiology, vol. 64, pp. 997–1002, 2014. View at Publisher · View at Google Scholar
  75. Y. Deng and P. H. Yu, “Assessment of the deamination of aminoacetone, an endogenous substrate for semicarbazide-sensitive amine oxidase,” Analytical Biochemistry, vol. 270, no. 1, pp. 97–102, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. F. Boomsma, A. H. van den Meiracker, S. Winkel et al., “Circulating semicarbazide-sensitive amine oxidase is raised both in Type I (insulin-dependent), in Type II (non-insulin-dependent) diabetes mellitus and even in childhood Type I diabetes at first clinical diagnosis,” Diabetologia, vol. 42, no. 2, pp. 233–237, 1999. View at Publisher · View at Google Scholar · View at Scopus
  77. C. Nigro, G. A. Raciti, A. Leone et al., “Methylglyoxal impairs endothelial insulin sensitivity both in vitro and in vivo,” Diabetologia, vol. 57, pp. 1485–1494, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. F. Fiory, A. Lombardi, C. Miele, J. Giudicelli, F. Beguinot, and E. van Obberghen, “Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E,” Diabetologia, vol. 54, no. 11, pp. 2941–2952, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. H.-Y. Li, M.-S. Lin, J.-N. Wei et al., “Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects,” Clinica Chimica Acta, vol. 403, no. 1-2, pp. 97–101, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. K. Aalto, A. S. Havulinna, S. Jalkanen, V. Salomaa, and M. Salmi, “Soluble vascular adhesion protein-1 predicts incident major adverse cardiovascular events and improves reclassification in a finnish prospective cohort study,” Circulation: Cardiovascular Genetics, vol. 7, no. 4, pp. 529–535, 2014. View at Publisher · View at Google Scholar
  81. H. Momma, K. Niu, Y. Kobayashi et al., “Skin advanced glycation end product accumulation and muscle strength among adult men,” European Journal of Applied Physiology, vol. 111, no. 7, pp. 1545–1552, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. J. C. Gallagher, “Vitamin D deficiency and muscle strength: are they related?” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 12, pp. 4366–4369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. J. M. Forbes, M. E. Cooper, V. Thallas et al., “Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy,” Diabetes, vol. 51, pp. 3274–3282, 2002. View at Publisher · View at Google Scholar
  84. M. Nangaku, T. Miyata, T. Sada et al., “Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model,” Journal of the American Society of Nephrology, vol. 14, no. 5, pp. 1212–1222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. K. Šebeková, K. Gazdíková, D. Syrová et al., “Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products,” Journal of Human Hypertension, vol. 17, no. 4, pp. 265–270, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. M. A. Albert, E. Danielson, N. Rifai, and P. M. Ridker, “Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study,” The Journal of the American Medical Association, vol. 286, no. 1, pp. 64–70, 2001. View at Publisher · View at Google Scholar · View at Scopus
  87. U. Landmesser, F. Bahlmann, M. Mueller et al., “Simvastatin versus ezetimibe pleiotropic and lipid-lowering effects on endothelial function in humans,” Circulation, vol. 111, no. 18, pp. 2356–2363, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. C. Antoniades, C. Bakogiannis, P. Leeson et al., “Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling,” Circulation, vol. 124, no. 3, pp. 335–345, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. Y. Jinnouchi, S. Yamagishi, M. Takeuchi et al., “Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes,” Clinical and Experimental Medicine, vol. 6, no. 4, pp. 191–193, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. P. Quade-Lyssy, A. M. Kanarek, M. Baiersdörfer, R. Postina, and E. Kojro, “Statins stimulate the production of a soluble form of the receptor for advanced glycation end products,” Journal of Lipid Research, vol. 54, no. 11, pp. 3052–3061, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. T. Sathyapalan, J. Shepherd, S. L. Atkin, and E. S. Kilpatrick, “The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover study,” Diabetes, Obesity and Metabolism, vol. 15, no. 8, pp. 767–769, 2013. View at Publisher · View at Google Scholar · View at Scopus
  92. C. J. Bailey, “Metformin: effects on micro and macrovascular complications in type 2 diabetes,” Cardiovascular Drugs and Therapy, vol. 22, no. 3, pp. 215–224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. K. Isoda, J. L. Young, A. Zirlik et al., “Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 3, pp. 611–617, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. D. Reid, B. J. Toole, S. Knox et al., “The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty,” American Journal of Clinical Nutrition, vol. 93, no. 5, pp. 1006–1011, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. P. Lee, J. A. Eisman, and J. R. Center, “Vitamin D deficiency in critically ill patients,” The New England Journal of Medicine, vol. 360, no. 18, pp. 1912–1914, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. Y.-T. Lee, H.-Y. Ng, C.-C. Kuo et al., “Comparison between calcitriol and calcitriol plus low-dose cinacalcet for the treatment of moderate to severe secondary hyperparathyroidism in chronic dialysis patients,” Nutrients, vol. 5, no. 4, pp. 1336–1348, 2013. View at Publisher · View at Google Scholar · View at Scopus
  97. G. Bjelakovic, L. L. Gluud, D. Nikolova et al., “Vitamin D supplementation for prevention of mortality in adults,” Cochrane Database of Systematic Reviews, no. 7, Article ID CD007470, 2014. View at Google Scholar · View at Scopus